Novo Nordisk’s Wegovy Wins EMA Flexibility In GLP-1 Access Push

Novo Nordisk has received EMA approval to allow Wegovy injections to be stored at up to 30°C for up to 48 hours. The change reduces strict cold chain requirements for pharmacies and online ...

Novo Nordisk A/S: Wegovy® injection becomes first GLP-1 weight-loss treatment approved for 48-hour controlled-temperature delivery in the EU

The European Medicines Agency (EMA) has approved an update to the product information for Wegovy ® injection that allows the ...
New York Post

FDA approves new daily Wegovy pill — and it’ll be available way sooner than you think

The weight-loss drug market just got more crowded — and a lot less painful. The FDA on Monday approved a daily pill version of Novo Nordisk’s Wegovy, making it the first oral GLP-1 obesity treatment ...

EU eases delivery requirement for Novo Nordisk’s Wegovy

Novo Nordisk (NVO) stock is in focus as the EU eases the cold-chain requirement that obesity injection, Wegovy, should be ...
WebMD

FDA Approves Once-Daily Wegovy Pill as the First Oral GLP-1 Medicine for Weight Loss in Adults With Obesity or Overweight

What Is Wegovy, and Why Does It Matter? Wegovy (semaglutide) is a prescription medicine that helps with weight loss and lowers the risk of heart problems and liver disease. The FDA has approved its ...
CBS News

FDA approves Wegovy pill for weight loss, the first daily oral medication of its kind

Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. The ...